The prior authorization numbers coming out of Medicare Advantage keep getting harder to explain away as noise. A KFF analysis published July 6 found MA insurers deny 65 percent of prior authorization requests for long-term care hospital stays and 54 percent of requests for inpatient rehabilitation facility stays. For skilled nursing facilities, the denial rate is 12 percent - but 95 percent of MA enrollees are now in a plan that requires prior auth for SNF stays, so that rate applies to nearly everyone.
For context, KFF's earlier analysis put the overall MA prior authorization denial rate below 8 percent for all services. Post-acute care is not the edge of the distribution. It is the target of it.
Why post-acute is different
Post-acute denials are uniquely expensive for providers, for three reasons:
- The care is already delivered. Unlike an imaging prior auth, a post-acute denial arrives after a patient has occupied a bed for days or weeks. The dispute is over care that has a cost basis attached.
- The stakes per case are high. A single denied LTCH or IRF stay can outweigh hundreds of routine claim denials. These are the accounts that can move a month's cash position.
- The appeals are documentation-heavy. Winning requires clinical records, physician attestations, and coverage-policy citations assembled under deadline - the most labor-intensive denial category there is.
Hospitals and post-acute providers have known this anecdotally for years. What the KFF data adds is scale: with insurers making nearly 53 million MA prior authorization determinations in 2024, even single-digit percentages translate into a very large volume of contested stays.
There is a timing squeeze built into these cases as well. Post-acute placement decisions happen at discharge, when the patient is ready and the bed is needed - so an authorization dispute stalls both the patient's care and the hospital's throughput. The cost of a slow appeal is not just the denied revenue; it is the downstream admissions that back up behind an unresolved discharge. Providers feel this as bed pressure and boarding time, which never appears on the denial report but shows up in capacity metrics every week.
The economics of appeal discipline
When denial rates run this high, the question stops being how to prevent denials - though prevention still matters - and becomes how efficiently each one is contested. That shifts the operating model:
Start with the queue you can see. Most post-acute billing teams underestimate how many denials never enter a workqueue at all - they arrive in a portal, sit in a PDF, and age in silence. Full denial capture is the precondition for everything below; you cannot work what you cannot see.
- Every post-acute denial gets appealed by default. At denial rates of 50 percent or more on some service lines, automatic appeal is cheaper than case-by-case triage, because the base rate of reversal is high.
- Speed is the controllable variable. Appeal windows and patient discharge timelines do not negotiate. Records gathering and letter drafting that start on day one fit inside deadlines; work started in week three does not.
- Pattern tracking feeds the next case. Which payers deny which levels of care, on what documentation grounds, is knowable from your own denial log. Teams that mine it draft stronger first appeals.
Measure the program the way you would any production line: cases worked versus cases received, median days from denial to filed appeal, reversal rate by payer and service line, and dollars recovered per case worked. Those four numbers separate an appeals operation from an appeals effort, and they turn every budget conversation from anecdote to arithmetic.
The organizations that succeed here also staff the function differently. Appeal writing is skilled work - clinical fluency, coverage policy knowledge, deadline discipline - and treating it as an administrative afterthought guarantees mediocre reversal rates. Whether the capacity comes from a dedicated team, a partner, or automation that assembles the packages humans then review, the point is that appeals get a real production process, not whatever time is left over after the phones.
The takeaway
A 65 percent denial rate on long-term care hospital authorizations is not a workflow nuisance; it is a payer pricing strategy that providers pay for in unrecovered revenue. The organizations that recover it treat appeals as a production discipline - every case worked, documentation assembled fast, deadlines tracked to the day. That is the work our agents do at QHB: read the denial, pull the records, draft the appeal, file it, and keep the clock. At denial rates like these, leaving cases unworked is the most expensive option on the menu.